ArticlePharmaceuticals (Basel, Switzerland)2025

Long-Term Cognitive Outcomes of Esketamine Nasal Spray in Treatment-Resistant Depression: A Preliminary Report.

Matildes de Freitas Menezes Sobreiro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.